Gastric bypass reduces mortality risk in severely obese patientsAugust 23, 2007Heart disease, cancer, diabetes death rates all drop in study Salt Lake City-Severely obese patients who undergo gastric bypass surgery significantly reduce their risk of death from coronary heart disease, diabetes, and cancer, according to research published in the Aug. 23, 2007, issue of The New England Journal of Medicine. The study was led by a team of researchers from the University of Utah School of Medicine and LDS Hospital. The 14-year study evaluated 15,850 severely obese patients, half of whom underwent gastric bypass surgery to reduce their weight. The mortality rate from coronary heart disease was 56 percent lower in the surgery group than in the non-surgery (control) group. The surgery group also showed a 60 percent lower death rate from cancer and a 92 percent lower death from diabetes than the non-surgery group, according to Ted D. Adams, Ph.D., M.P.H., the study's lead author,
Adams is a professor in the Division of Cardiovascular Genetics at the University of Utah School of Medicine and co-founder of the Intermountain Health and Fitness Institute at LDS Hospital in Salt Lake City. While mortality rates for specific diseases were lower in the surgery group, Adams said mortality rates from other causes - such as accidents and suicide - were 58 percent higher among those who had the weight loss surgery than the control group. "This study helps to further define the effects of gastric bypass surgery on long-term mortality. Reduction in death by any cause, and disease-specific deaths such as coronary heart disease, diabetes, and cancer were significantly reduced in surgery patients compared to the non-surgical control group," he said. "However, rates of death not caused by disease were shown to be greater in those who underwent the weight-loss surgery when compared to controls." The paper suggests at least some of these non-disease deaths in the surgery group may be due to unrecognized pre-surgical mood disorders or post-traumatic stress disorders, which appear to be more common in severely obese patients. Adams said the research shows the need for better methods of evaluating candidates for the surgery, including the possible need for psychological evaluation and psychiatric treatment before surgery, and aggressive follow-up after surgery. The reduced mortality for any cause of death is likely related to significant health improvements that follow gastric bypass surgery, such as reduced blood pressure, improved or resolved diabetes, and reduced sleep apnea, says Adams. Women accounted for 84 percent of the patients involved in the study. The average body mass index (BMI), which is calculated by dividing a person's weight in kilograms by the square of the person's height, for patients in the surgery group was 45.3, and 46.7 for the non-surgery group. University of Utah Health Sciences Center Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Neurogenesis Nutrition Virtual Reality Ear Infections Discrimination Radiation Therapy Brain Imaging Cancer Diagnosis Sea Turtles Lung Disease Meditation Depression Primary Care Cancer Survivors Mobile Phone Cosmic Rays Hiv-infected Coffee Mass Extinction Chromatin Schizophrenia Giant Panda Staph Infection Angiogenesis Prion
See More: Science News Tags | |||||||||||||||||||||
|
Related Gastric Bypass Current Events and Gastric Bypass News Articles Lap-band weight-loss surgery can reverse metabolic syndrome in obese teens A new study of obese adolescents has shown that laparoscopic gastric banding surgery -- the "Lap-Band" procedure -- not only helps them achieve significant weight loss but can also improve and even reverse metabolic syndrome, reducing their risk for cardiovascular disease and diabetes. Roux-en-Y weight loss surgery raises kidney stone risk The most popular type of gastric bypass surgery appears to nearly double the chance that a patient will develop kidney stones, despite earlier assumptions that it would not, Johns Hopkins doctors report in a new study. Fatty foods -- not empty stomach -- fire up hunger hormone New research led by the University of Cincinnati (UC) suggests that the hunger hormone ghrelin is activated by fats from the foods we eat-not those made in the body-in order to optimize nutrient metabolism and promote the storage of body fat. Study shows potential for resolving type 2 diabetes with bariatric surgery As the incidence of obesity-induced type 2 diabetes mellitus continues to increase worldwide, medical research indicates that surgery to reduce obesity can completely eliminate all manifestations of diabetes. Obesity linked to hormone imbalance that impacts sexual quality of life Hormonal changes and diminished sexual quality of life among obese men are related to the degree of obesity, and both are improved after gastric bypass surgery according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). Our microbes, ourselves In terms of diversity and sheer numbers, the microbes occupying the human gut easily dwarf the billions of people inhabiting the Earth. Numbering in the tens of trillions and representing many thousands of distinct genetic families, this microbiome, as it's called, helps the body perform a variety of regulatory and digestive functions, many still poorly understood. Sealing off portion of intestinal lining treats obesity, resolves diabetes in animal model Lining the upper portion of the small intestine with an impermeable sleeve led to both weight loss and restoration of normal glucose metabolism in an animal model of obesity-induced diabetes. Physical activity after bariatric surgery improves weight loss, quality of life A new study by researchers from The Miriam Hospital's Centers for Behavioral and Preventive Medicine suggests increased physical activity after bariatric surgery can yield better postoperative outcomes. New promising obesity drug may have huge potential According to trials, a new obesity drug, Tesofensine, which may be launched on the world market in a few years, can produce weight loss twice that of currently approved obesity drugs. Selecting appropriate massive weight loss patients for body contouring critical The importance of pre-operative screening for patients seeking body contouring after massive weight loss will be assessed in three studies presented at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2008 conference, Oct. 31 - Nov. 5, in Chicago. More Gastric Bypass Current Events and Gastric Bypass News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||